AmerisourceBergen Corporation (ABC) Bundle
An Overview of AmerisourceBergen Corporation (ABC)
General Summary of AmerisourceBergen Corporation (ABC)
AmerisourceBergen Corporation (ABC), established in 2001 through the merger of Amerisource Health Corporation and Bergen Brunswig Corporation, is a leading pharmaceutical sourcing and distribution services company. The firm specializes in providing pharmaceutical products and healthcare services to healthcare providers, including hospitals and pharmacies. As of 2024, the company operates through two primary segments: U.S. Healthcare Solutions and International Healthcare Solutions.
In fiscal year 2024, AmerisourceBergen generated total revenues of $294.0 billion, reflecting a 12.1% increase from the previous fiscal year. The U.S. Healthcare Solutions segment accounted for approximately $71.7 billion in revenue, while the International Healthcare Solutions segment contributed $7.4 billion.
Company's Financial Performance in the Latest Financial Reports
In the fourth quarter of fiscal 2024, AmerisourceBergen reported revenues of $79.1 billion, marking a 14.7% increase year-over-year. This growth was driven by a 15.7% increase in revenue from U.S. Healthcare Solutions and a 5.5% increase from International Healthcare Solutions.
Key financial metrics for the fourth quarter of fiscal 2024 include:
| Metric | Q4 FY 2024 | Q4 FY 2023 | Change |
|---|---|---|---|
| Revenue | $79.1 billion | $68.9 billion | +14.7% |
| Gross Profit | $2.5 billion | $2.3 billion | +10.6% |
| Operating Income | $126.6 million | $475.2 million | -73.4% |
| Diluted EPS | $0.02 | $1.72 | -98.8% |
| Adjusted Diluted EPS | $3.34 | $2.86 | +16.8% |
For the entire fiscal year 2024, the adjusted operating income reached $3.6 billion, a 10.9% increase from the previous year. The adjusted diluted EPS for the year was $13.76, up from $11.99.
Introduction to the Company as a Leader in the Industry
AmerisourceBergen is recognized as one of the largest pharmaceutical distributors in the world, playing a critical role in the healthcare supply chain. The company's strategic focus on enhancing its pharmaceutical distribution capabilities has positioned it favorably within the industry. Its robust logistics and technology infrastructure supports a wide range of healthcare providers, ensuring efficient delivery of critical medications and healthcare products.
In addition, AmerisourceBergen's commitment to innovation and customer-centric solutions has been pivotal in maintaining its leadership status. The company continues to expand its global footprint, evidenced by its recent acquisition of Retina Consultants of America, which underscores its strategy to enhance specialty healthcare services.
Mission Statement of AmerisourceBergen Corporation (ABC)
Mission Statement Overview
The mission statement of AmerisourceBergen Corporation (ABC) reflects its commitment to improving patient access to healthcare through the distribution of pharmaceutical products and services. The company's mission emphasizes a customer-centric approach, aiming to enhance the healthcare supply chain while maintaining high-quality standards in its offerings.
Core Component 1: Customer-Centric Focus
AmerisourceBergen prioritizes its customers by offering tailored solutions that meet their unique needs. This approach is evidenced by a substantial revenue increase in its U.S. Healthcare Solutions segment, which reported $71.7 billion in revenue for the fourth quarter of fiscal 2024, a 15.7% increase from the previous year. The company’s focus on customer service is integral to its mission, ensuring that healthcare providers have the resources necessary to deliver effective patient care.
Core Component 2: Commitment to Quality
The company is dedicated to providing high-quality products and services. For fiscal year 2024, AmerisourceBergen achieved an adjusted gross profit of $9.7 billion, an 8.1% increase from the prior year. This commitment is reflected in the company’s stringent quality control measures and adherence to regulatory standards, ensuring that all products meet the highest safety and efficacy benchmarks.
Core Component 3: Innovation and Growth
Innovation is a cornerstone of AmerisourceBergen's mission, driving the company to continuously improve and expand its service offerings. The company reported total revenue of $294.0 billion for fiscal year 2024, reflecting a 12.1% growth compared to the previous year. This growth is supported by strategic acquisitions and investments in technology that enhance operational efficiency and customer engagement.
| Financial Metric | FY 2023 | FY 2024 | Change (%) |
|---|---|---|---|
| Revenue | $262.2 billion | $294.0 billion | 12.1% |
| Adjusted Gross Profit | $9.0 billion | $9.7 billion | 8.1% |
| Adjusted Operating Income | $3.3 billion | $3.6 billion | 10.9% |
| Adjusted Diluted EPS | $11.99 | $13.76 | 14.8% |
AmerisourceBergen’s mission statement underscores its dedication to enhancing healthcare delivery through a focus on customer service, quality, and innovation. The company’s financial performance in fiscal year 2024 demonstrates its effectiveness in executing this mission, as reflected in the significant growth across key financial metrics.
Vision Statement of AmerisourceBergen Corporation (ABC)
Vision Statement Overview
The vision statement of AmerisourceBergen Corporation (ABC) emphasizes its commitment to being a leader in healthcare distribution, focusing on improving patient outcomes by providing innovative solutions and services. This vision aligns with their strategic goals and operational objectives as they navigate the complexities of the healthcare landscape in 2024.
Commitment to Patient-Centric Solutions
AmerisourceBergen aims to enhance patient care through a focus on patient-centric solutions. This includes the provision of advanced pharmaceutical distribution services and support for healthcare providers. As of fiscal year 2024, the company reported a revenue increase to $294.0 billion, a 12.1 percent year-over-year growth, reflecting its commitment to delivering value in healthcare.
Innovation and Technology Integration
Innovation is a core component of AmerisourceBergen's vision. The company invests significantly in technology to streamline operations and improve service delivery. In fiscal 2024, the company recorded an adjusted operating income of $3.6 billion, indicating effective management and innovation in its operational strategies.
Global Reach and Market Leadership
AmerisourceBergen's vision includes expanding its global footprint. The company operates under two segments: U.S. Healthcare Solutions and International Healthcare Solutions. In the fourth quarter of fiscal 2024, the U.S. Healthcare Solutions segment generated $71.7 billion in revenue, up 15.7 percent from the previous year. The International Healthcare Solutions segment also saw a revenue increase to $7.4 billion, marking a 5.5 percent growth.
Commitment to Sustainability and Ethical Practices
AmerisourceBergen is dedicated to sustainability and ethical business practices, which are integral to its vision. The company has undertaken initiatives to reduce its environmental impact and enhance its corporate social responsibility. The fiscal year 2024 saw an increase in operating expenses to $7.7 billion, reflecting investments in sustainable practices and compliance.
Financial Performance and Future Growth
The financial performance of AmerisourceBergen in 2024 illustrates its strong market position and commitment to growth. The company reported diluted earnings per share (EPS) of $7.53 for fiscal 2024, a decrease from the prior year, but adjusted diluted EPS rose to $13.76, indicating robust operational performance. The strategic initiatives outlined in their vision are expected to drive future growth, with guidance for adjusted diluted EPS growth of 8 percent to 10 percent for fiscal year 2025.
| Metric | Fiscal Year 2024 | Fiscal Year 2023 | Year-over-Year Change |
|---|---|---|---|
| Revenue | $294.0 billion | $262.2 billion | 12.1% |
| Adjusted Operating Income | $3.6 billion | $3.2 billion | 10.9% |
| Diluted EPS (GAAP) | $7.53 | $8.53 | (11.7%) |
| Adjusted Diluted EPS | $13.76 | $11.99 | 14.8% |
| Operating Expenses | $7.7 billion | $6.6 billion | 16.9% |
Core Values of AmerisourceBergen Corporation (ABC)
Integrity
The core value of integrity at AmerisourceBergen Corporation emphasizes the importance of being honest and ethical in all business dealings. This value is crucial as it builds trust with partners, customers, and stakeholders.
In 2024, AmerisourceBergen has demonstrated its commitment to integrity through various initiatives, including compliance programs that ensure adherence to legal and regulatory standards. The company reported a net income attributable to Cencora of $1.5 billion for fiscal year 2024, reflecting its focus on ethical business practices that enhance its reputation .
Accountability
Accountability at AmerisourceBergen means taking responsibility for actions and outcomes. This value is vital for fostering a culture of ownership and transparency within the organization.
The company’s adjusted operating income for the fourth quarter of fiscal 2024 was $851.1 million, showcasing its commitment to meeting financial targets and holding teams accountable for performance. Additionally, AmerisourceBergen has implemented performance metrics that align with its strategic goals, ensuring that employees are accountable for their contributions to the company's success.
Collaboration
Collaboration is a core value that drives teamwork and partnership, both internally and externally. This value is essential for creating innovative solutions and enhancing service delivery.
In fiscal year 2024, AmerisourceBergen reported a revenue increase of 12.1 percent, totaling $294.0 billion, attributed to effective collaboration across its U.S. and International Healthcare Solutions segments. The company has also focused on strategic partnerships, such as its acquisition of Retina Consultants of America, which aims to enhance its specialty services .
Excellence
The pursuit of excellence is a fundamental value at AmerisourceBergen, driving the company to deliver high-quality products and services. This commitment to excellence enhances customer satisfaction and operational efficiency.
For the fourth quarter of fiscal 2024, AmerisourceBergen achieved a gross profit of $2.5 billion, reflecting a 10.6 percent increase from the previous year. The company continues to invest in technology and training programs that improve service delivery and operational effectiveness, thereby reinforcing its commitment to excellence.
Innovation
Innovation is a core value that encourages creativity and the development of new solutions to meet evolving healthcare needs. This value is critical for maintaining competitiveness in the rapidly changing healthcare landscape.
AmerisourceBergen has made significant strides in innovation, as evidenced by its investment in advanced distribution technologies that support its operations globally. The company’s adjusted operating income margin of 1.24 percent for fiscal year 2024 reflects its successful implementation of innovative practices that drive profitability.
| Core Value | Description | Key Performance Indicator | Fiscal Year 2024 Result |
|---|---|---|---|
| Integrity | Commitment to ethical business practices | Net Income Attributable to Cencora | $1.5 billion |
| Accountability | Responsibility for actions and outcomes | Adjusted Operating Income | $851.1 million |
| Collaboration | Teamwork and partnership | Revenue Growth | $294.0 billion |
| Excellence | High-quality products and services | Gross Profit | $2.5 billion |
| Innovation | Creativity in solutions | Adjusted Operating Income Margin | 1.24% |
AmerisourceBergen Corporation (ABC) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Updated on 16 Nov 2024
Resources:
- AmerisourceBergen Corporation (ABC) Financial Statements – Access the full quarterly financial statements for Q4 2024 to get an in-depth view of AmerisourceBergen Corporation (ABC)' financial performance, including balance sheets, income statements, and cash flow statements.
- SEC Filings – View AmerisourceBergen Corporation (ABC)' latest filings with the U.S. Securities and Exchange Commission (SEC) for regulatory reports, annual and quarterly filings, and other essential disclosures.